Welcome to the latest edition of the MassDevice.com’s D+Vice Talk, our new webcast, in which we review medical device stories from the last week.
In this episode we discuss the Senate vote to repeal the medical device tax, the Office of the Inspector General’s warning on physician-owned distributorships and the latest rumbles about St. Jude Medical’s (NYSE:STJ) next-generation Durata defibrillator leads.
Find all of today’s referenced stories here:
- The Senate’s medtech tax repeal vote
- OIG: Docs with financial incentives for implantable devices are "inherently suspect"
- Will another Durata failure report drag St. Jude down?